2nd Quarter - Report

THE MCMANUS GROUP for ACHAOGEN

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Education and advocacy regarding continued appropriations for antibacterial funding initiatives.

LobbyistCovered position, as disclosed
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act.; Food and Drug Administration legislative and regulatory issues.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
CHASE M THOMAS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 512 (114th), H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.